Capital Investment Advisory Services, LLC Crispr Therapeutics Ag Transaction History

Capital Investment Advisory Services, LLC

  • $972 Million
  • Q4 2024

A detailed history of Capital Investment Advisory Services, LLC transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Capital Investment Advisory Services, LLC holds 22,265 shares of CRSP stock, worth $976,097. This represents 0.09% of its overall portfolio holdings.

Number of Shares
22,265
Previous 25,259 11.85%
Holding current value
$976,097
Previous $1.19 Million 26.14%
% of portfolio
0.09%
Previous 0.12%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 23, 2025
SELL
$38.65 - $55.15 $115,718 - $165,119
-2,994 Reduced 11.85%
22,265 $876,000
Q3 2024

Oct 30, 2024
SELL
$44.62 - $62.75 $210,918 - $296,619
-4,727 Reduced 15.76%
25,259 $1.19 Million
Q2 2024

Aug 14, 2024
SELL
$51.17 - $68.18 $6,038 - $8,045
-118 Reduced 0.39%
29,986 $1.62 Million
Q1 2024

Apr 25, 2024
SELL
$60.67 - $89.12 $92,946 - $136,531
-1,532 Reduced 4.84%
30,104 $2.05 Million
Q4 2023

Feb 01, 2024
BUY
$38.62 - $72.18 $33,020 - $61,713
855 Added 2.78%
31,636 $1.98 Million
Q3 2023

Nov 02, 2023
BUY
$45.39 - $59.0 $41,985 - $54,575
925 Added 3.1%
30,781 $1.4 Million
Q2 2023

Jul 28, 2023
BUY
$43.47 - $67.77 $20,996 - $32,732
483 Added 1.64%
29,856 $1.68 Million
Q1 2023

Apr 21, 2023
BUY
$41.0 - $56.12 $86,428 - $118,300
2,108 Added 7.73%
29,373 $1.33 Million
Q4 2022

Feb 03, 2023
SELL
$39.19 - $65.67 $80,574 - $135,017
-2,056 Reduced 7.01%
27,265 $1.11 Million
Q3 2022

Oct 26, 2022
BUY
$61.1 - $83.78 $66,721 - $91,487
1,092 Added 3.87%
29,321 $1.92 Million
Q2 2022

Jul 22, 2022
BUY
$43.23 - $73.83 $53,691 - $91,696
1,242 Added 4.6%
28,229 $1.72 Million
Q1 2022

May 03, 2022
BUY
$53.19 - $79.24 $350,575 - $522,270
6,591 Added 32.32%
26,987 $1.69 Million
Q4 2021

Feb 01, 2022
SELL
$70.09 - $111.29 $118,311 - $187,857
-1,688 Reduced 7.64%
20,396 $1.55 Million
Q3 2021

Oct 28, 2021
SELL
$110.2 - $156.64 $58,295 - $82,862
-529 Reduced 2.34%
22,084 $2.47 Million
Q2 2021

Jul 27, 2021
BUY
$100.84 - $161.89 $187,360 - $300,791
1,858 Added 8.95%
22,613 $3.66 Million
Q1 2021

May 05, 2021
BUY
$110.72 - $210.04 $445,648 - $845,411
4,025 Added 24.06%
20,755 $2.53 Million
Q4 2020

Jan 25, 2021
SELL
$79.67 - $173.23 $424,800 - $923,662
-5,332 Reduced 24.17%
16,730 $2.56 Million
Q3 2020

Oct 19, 2020
SELL
$78.5 - $100.64 $374,837 - $480,556
-4,775 Reduced 17.79%
22,062 $1.85 Million
Q2 2020

Aug 05, 2020
BUY
$38.5 - $76.05 $92,169 - $182,063
2,394 Added 9.79%
26,837 $1.97 Million
Q1 2020

Apr 28, 2020
BUY
$33.68 - $62.53 $31,490 - $58,465
935 Added 3.98%
24,443 $1.04 Million
Q4 2019

Feb 04, 2020
SELL
$36.68 - $73.13 $2,384 - $4,753
-65 Reduced 0.28%
23,508 $1.43 Million
Q3 2019

Oct 17, 2019
SELL
$40.99 - $52.56 $28,488 - $36,529
-695 Reduced 2.86%
23,573 $966,000
Q2 2019

Aug 08, 2019
BUY
$35.45 - $48.2 $50,126 - $68,154
1,414 Added 6.19%
24,268 $1.2 Million
Q1 2019

Apr 23, 2019
SELL
$28.02 - $40.87 $67,948 - $99,109
-2,425 Reduced 9.59%
22,854 $816,000
Q4 2018

Feb 04, 2019
BUY
$22.73 - $42.34 $190,386 - $354,639
8,376 Added 49.55%
25,279 $722,000
Q3 2018

Oct 30, 2018
SELL
$44.35 - $65.71 $47,011 - $69,652
-1,060 Reduced 5.9%
16,903 $750,000
Q2 2018

Aug 01, 2018
BUY
$42.62 - $73.59 $162,083 - $279,862
3,803 Added 26.86%
17,963 $1.06 Million
Q1 2018

Apr 30, 2018
BUY
$23.52 - $58.17 $90,787 - $224,536
3,860 Added 37.48%
14,160 $647,000
Q4 2017

Jan 31, 2018
SELL
$16.95 - $23.48 $8,475 - $11,740
-500 Reduced 4.63%
10,300 $242,000
Q3 2017

Oct 31, 2017
BUY
$16.75 - $20.66 $180,900 - $223,128
10,800
10,800 $193,000

Others Institutions Holding CRSP

# of Institutions
487
Shares Held
64.1M
Call Options Held
1.64M
Put Options Held
1.93M
View Full List

About CRISPR Therapeutics AG

CRSP Quotes by TradingView
  • Ticker CRSP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,009,296
  • Market Cap $3.42B
  • Description
  • CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....
More about CRSP
Track This Portfolio

Track Capital Investment Advisory Services, LLC Portfolio

Follow Capital Investment Advisory Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Investment Advisory Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capital Investment Advisory Services, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email